NVAX
NASDAQStockNovavax, Inc.
$10.38-0.42 (-3.94%)
52-Week Range
$5.43
$11.19
Key Stats
Market Cap
1.7B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.63
Volume
2.9M
Avg Volume
6.1M
Performance
1M
+14.83%
3M
+56.53%
6M
+27.48%
YTD
+44.46%
1Y
+26.07%
3Y
+64.27%
5Y
-95.26%
Price Chart
ETF Exposure
NVAX is held by 80 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| MFUS | PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF | 0.01% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.01% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.01% |
| VALT | ETFMG Sit Ultra Short ETF | 0.01% |
| AVUQ | Avantis U.S. Quality ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| DFAS | Dimensional - US Small Cap ETF | 0.00% |
| DXUV | Dimensional - US Vector Equity ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
PreviousPage 2 of 2
About NVAX ETF Exposure
Novavax, Inc. (NVAX) is held by 80 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.7B, NVAX is a widely held institutional stock. The stock currently trades at $10.38. Investors can gain exposure to NVAX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NVAX, sorted by portfolio weight.